About Our Company
America Great Health operates as a biotechnology company. The Company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
"Caring for life and pursuing excellence"
Protein & Peptide Research
Small molecular drugs research and development
AI & Medical Devices
Diagnostic and medical devices with AI cloud computing
Regenerative Medicine
Cell therapy, regenerative medicine and supplements
Healthcare Ecosystem
Technology integration and business development
Historical Development
From Crown Marketing to America Great Health
America Great Health, formerly Crown Marketing, is a Wyoming corporation. The change of ownership of the Company was completed on January 19, 2017, from Jay Hooper, the former officer of the Company and its former majority shareholder. Control was obtained by the sale of 16,155,746,000 shares of Company common stock from Mr. Hooper to an investor group led by Mike Q. Wang.
On March 1, 2017, the Company filed with the Secretary of State of the State of Wyoming an Articles of Amendment to change the corporate name from Crown Marketing to America Great Health. Following the name change, the Company applied for a change of its stock ticker symbol from CWNM to AAGH. The application was approved by FINRA. Our stocks are now trading under the new ticker symbol AAGH.
On March 9, 2017, the Company formed a wholly owned subsidiary, America Great Health, under the laws of the State of California.
Corporate Milestones
Acquisition & Control
Jan 2017The investors' group led by Mike Wang gained control over the Company by acquiring 16,155,746,000 ordinary shares in Crown Marketing.
Rebranding
March 2017The Company changed its name from Crown Marketing to America Great Health and changed its stock code from CWNM to AAGH.
Middle East Expansion
Nov 2018AAGH Middle East Office was established.
Hong Kong Office
May 2019AAGH Hong Kong Office was established.
China Subsidiary
Jun 2019Meizhong Health Industry Development Co., Ltd., a wholly-owned subsidiary of AAGH in China, was established with a registered capital of CNY 200 million.
Sydney Office
Jul 2019AAGH Sydney Office was established.
Bangkok Office
Nov 2019AAGH Bangkok Office was established.
Toronto Office
Aug 2020AAGH Toronto Office was established.
Singapore Office
Oct 2020AAGH Singapore Office was established.
Research Institute
Oct 2020International Institute of Great Health was established.
Taiwan Office
Jan 2021AAGH Taiwan Office was established.
Development Objectives
Our Vision for the Future
Under the core concept of "Caring for Life and Pursuing Excellence", the Company is committed to the development of health products, pharmaceutical industry, and human health. We strive to build an aircraft carrier in the great health industry that can withstand storms and waves and sustain long voyages, and will finally become an influential international promotion platform for the medical care and great health industry's finance, technology and products.
Our Research Capabilities
Advanced Microscopy
Laboratory Centrifuge
.png&w=828&q=75)
PCR Thermocycler
Tissue Culture Hood
.png&w=828&q=75)
Laboratory Refrigeration
Web Laboratory